Dequilla, Jesus M.

HRN: 18-20-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/18/2023
05/25/2023
IV
600mg
OD
Cathether Associated UTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: